ATOSSA THERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
ATOSSA THERAPEUTICS, INC. has filed 636 SEC EDGAR filings since 30 Mar 2010

SEC filing history

Showing 51-75 of 636 matching filings.

Per page
25
Current page
3
4

4

Filing date
16 May 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 May 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 May 2025
Reporting date
15 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Mar 2025
Reporting date
26 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-35610

ARS

Filing date
26 Mar 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35610

DEF 14A

Filing date
26 Mar 2025
Reporting date
26 Mar 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-87057

SCHEDULE 13G/A filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-279367

424B5

Filing date
19 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87057

SC 13G/A filing

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87057

SC 13G filing

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87057

SC 13G/A filing

Filing date
04 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .